论文部分内容阅读
近年来我们应用德诺(De—Nol)治疗消化性溃疡64例,同时与用法莫替丁治疗消化性溃疡32例作对照,观察其临床疗效,现报告如下。 1.临床资料 96例消化性溃疡均经纤维胃镜检查确诊,其中胃溃疡42例,十二指肠球部溃疡54例。在胃镜检同时取活检作尿素酶快速诊断试验与细菌学涂片染色。两项中一项阳性者即判为幽门螺杆菌感染。溃疡直径≥0.5cm。 治疗组64例中,男56例,女8例。年龄18～74岁,平均44.5岁。对照组32例中,男25例,女7例。年龄与病情基本同治疗组。 治疗组幽门螺杆菌(HP)阳性率为87.5％,对照组为90.6％,治疗组口服德诺,每次240mg,每日二次,于
In recent years, we use De Nuo (De-Nol) treatment of peptic ulcer in 64 cases, while with famotidine in the treatment of peptic ulcer in 32 cases as control, observe its clinical efficacy, are as follows. 1. Clinical data 96 cases of peptic ulcer were diagnosed by gastroscopy, gastric ulcer in 42 cases, 54 cases of duodenal ulcer. At the same time in the gastroscopy biopsy for urease rapid diagnostic test and bacteriological smear. One of the two positives was convicted of Helicobacter pylori infection. Ulcer diameter ≥ 0.5cm. 64 cases in the treatment group, 56 males and 8 females. Age 18 to 74 years old, average 44.5 years old. Control group of 32 patients, 25 males and 7 females. The same age and disease treatment group. In the treatment group, the positive rate of Helicobacter pylori (HP) was 87.5% and that of the control group was 90.6%. The treatment group was given Deprotral twice a day (240mg twice daily)